Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.1K

The L-type calcium channel CaV1.3: A potential target for cancer therapy

Xuerun Liu1, Boqiang Shen1, Jingyi Zhou1

  • 1Department of Gynecology and Obstetrics, Peking University People's Hospital, Beijing, China.

Journal of Cellular and Molecular Medicine
|October 4, 2024
PubMed

Insights

This review explores the role of L-type calcium channels (CaV1.3) in cancer progression and treatment resistance. Selective CaV1.3 blockers show promise as a new targeted therapy for cancers like prostate and endometrial cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Calcium (Ca2+) signaling is crucial in cancer progression, influencing proliferation, invasion, and metastasis.
  • Ca2+ signaling also impacts cancer therapy resistance, affecting treatment efficacy.
  • The L-type calcium channel CaV1.3 (calcium voltage-gated channel subunit alpha1 D) is implicated in various cancers.

Purpose of the Study:

  • To review the role of CaV1.3 in different cancer types.
  • To highlight CaV1.3 as a potential therapeutic target.
  • To discuss the development of selective CaV1.3 blockers for cancer treatment.

Main Methods:

  • Literature review of studies on CaV1.3 in cancer.
  • Analysis of pharmacological properties of CaV1.3.
  • Assessment of the current status of selective CaV1.3 blocker development.

Main Results:

  • CaV1.3 plays a significant role in cancer progression and therapy resistance.
  • Selective CaV1.3 blockers are of great interest for targeted cancer therapy.
  • Potential applications include prostate and endometrial cancer treatment.

Conclusions:

  • CaV1.3 is a promising therapeutic target for specific cancer types.
  • Development of selective CaV1.3 blockers offers a new treatment option.
  • Further research is needed to overcome challenges in developing tailored CaV1.3-targeted medicines.
Keywords:
CACNA1DL‐type calcium channelcalcium channel blockerscancertargeted therapy

More Related Videos

Expression and Purification of the Human Lipid-sensitive Cation Channel TRPC3 for Structural Determination by Single-particle Cryo-electron Microscopy08:27

Expression and Purification of the Human Lipid-sensitive Cation Channel TRPC3 for Structural Determination by Single-particle Cryo-electron Microscopy

Published on: January 7, 2019

9.4K
Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels07:17

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels

Published on: December 13, 2024

609

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
469
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.7K